Terguride - Medac

Drug Profile

Terguride - Medac

Alternative Names: Terguride hydrogen maleate

Latest Information Update: 26 Sep 2016

Price : $50

At a glance

  • Originator Medac
  • Class Antiparkinsonians; Antipsychotics; Ergolines; Neuroprotectants; Small molecules; Urea compounds
  • Mechanism of Action Dopamine receptor modulators; Serotonin receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Systemic scleroderma

Most Recent Events

  • 26 Sep 2016 Chemical structure information added
  • 03 Aug 2016 Phase-III clinical trials in Systemic scleroderma in Germany (PO) (EudraCT2015-002586-39)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top